Stay updated on Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study details with a standard error screen and site footer.
    Difference
    18%
    Check dated 2026-09-21T20:34:41.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The study overview no longer displays the condition 'Melanoma' and the related topic links (MedlinePlus Genetics), reducing visibility of the disease context and related resources on the page.
    Difference
    0.2%
    Check dated 2026-09-07T20:56:47.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now includes Melanoma as a topic and related topics such as MedlinePlus Genetics, and the revision tag has been updated from v3.6.5 to v3.6.6. This updates contextual metadata and navigation references without altering the study data or outcomes.
    Difference
    0.2%
    Check dated 2026-08-31T17:48:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    An NIH funding annotation, “2016 ( U.S. NIH Grant/Contract ),” was added to the study's identifying numbers. This connects the grant/contract information with the existing identifiers for the trial.
    Difference
    0.1%
    Check dated 2026-08-24T16:35:50.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The study's condition label Melanoma and related resources (related topics: and MedlinePlus Genetics) have been removed from the page. This indicates a restructuring of the study’s condition labeling and its related-resource references.
    Difference
    0.2%
    Check dated 2026-08-17T13:57:55.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 label was added to the page, indicating an update. The Investigator Inquiry Form was removed, and the previous Revision: v3.6.4 entry was deleted.
    Difference
    0.1%
    Check dated 2026-08-10T10:39:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.